首页> Cancer research> Therapeutically Targetable ALK Mutations in Leukemia.

Therapeutically Targetable ALK Mutations in Leukemia.

导出 OA

翻译打印收藏纠错

第一作者： Julia E,Maxson

第一单位： Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon. Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon.

作者： Julia E,Maxson ^[1] ; Monika A,Davare ^[2] ; Samuel B,Luty ^[1] ; Christopher A,Eide ^[3] ; Bill H,Chang ^[2] ; Marc M,Loriaux ^[1] ; Cristina E,Tognon ^[3] ; Daniel,Bottomly ^[4] ; Beth,Wilmot ^[5] ; Shannon K,McWeeney ^[5] ; Brian J,Druker ^[3] ; Jeffrey W,Tyner ^[6]

作者单位： Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon. Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon. ^[1] Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon. Division of Hematology and Oncology, Department of Pediatrics, Oregon Health and Science University, Portland, Oregon. ^[2] Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon. Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon. Howard Hughes Medical Institute, Chevy Chase, Maryland. ^[3] Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon. Oregon Clinical and Translational Research Institute, Oregon Health and Science University, Portland, Oregon. ^[4] Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon. Oregon Clinical and Translational Research Institute, Oregon Health and Science University, Portland, Oregon. Division of Bioinformatics and Computational Biology, Oregon Health and Science University, Portland, Oregon. ^[5] Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon. Department of Cell and Developmental Biology, Oregon Health and Science University, Portland, Oregon. tynerj@ohsu.edu. ^[6]